AVITA Medical CFO buys 2,000 shares on market

AVITA Medical, Inc. (RCEL) officer David D. O'Toole, the CFO, reported an amended insider transaction.

Rhea-AI Filing Summary

AVITA Medical, Inc. (RCEL) officer David D. O'Toole, the CFO, reported an amended insider transaction. On June 12, 2026, he purchased 2,000 shares of AVITA Medical common stock at $3.97 per share in an open market or private transaction. This amendment corrects the original filing’s transaction code from “A” to “P”. Following the purchase, his directly held position is 152,927 shares, which includes unvested RSUs.

Insider Trade Summary

Net Buyer: 2,000 shares

Net Buy 1 txn

Insider O'Toole David D

Role CFO

Bought 2,000 shs ($8K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	2,000	$3.97	$8K

Holdings After Transaction: Common Stock — 152,927 shares (Direct)

Footnotes (2)

1. F1. The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code.
2. F2. Includes unvested RSUs

Key Figures

Shares purchased: 2,000 shares Purchase price per share: $3.97 per share Shares held after transaction: 152,927 shares +1 more

4 metrics

Shares purchased 2,000 shares Common Stock purchase on June 12, 2026

Purchase price per share $3.97 per share Open market or private transaction on June 12, 2026

Shares held after transaction 152,927 shares Direct holdings after June 12, 2026 transaction, includes unvested RSUs

Net buy shares reported 2,000 shares Net buy direction across all transactions in this Form 4/A

Key Terms

Form 4/A, transaction code, RSUs, open market or private transaction

4 terms

Form 4/A regulatory

"The original Form 4, filed on June 12, 2026, inadvertently used"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

transaction code regulatory

"inadvertently used transaction code 'A' instead of transaction code 'P'"

RSUs financial

"Includes unvested RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

open market or private transaction market

"transaction code 'P' describes a Purchase in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RCEL CFO David O'Toole report in this Form 4/A?

He reported a purchase of 2,000 shares of AVITA Medical, Inc. common stock on June 12, 2026, classified as a purchase in an open market or private transaction at a price of $3.97 per share.

Why was this Form 4/A filing for RCEL an amendment?

The filing states that the original Form 4 filed on June 12, 2026 inadvertently used transaction code “A” instead of transaction code “P”. This amendment corrects the transaction code to properly reflect a purchase.

How many RCEL shares does CFO David O'Toole hold after this transaction?

After the reported purchase, David O'Toole directly holds 152,927 shares of AVITA Medical, Inc. common stock. A footnote clarifies that this amount includes unvested RSUs.

What was the price paid per RCEL share in the reported transaction?

The filing reports that the 2,000 shares of AVITA Medical, Inc. common stock were purchased at $3.97 per share in an open market or private transaction.

Was the RCEL insider transaction made under a Rule 10b5-1 trading plan?

The document-level checkbox for Rule 10b5-1 is not checked, and the footnotes do not state that the June 12, 2026 purchase was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:01 PM EDT Accepted by SEC EDGAR 08/24/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Toole David D

(Last) (First) (Middle)

28159 AVENUE STANFORD

SUITE 220 - AVITA MEDICAL

(Street)

VALENCIA CALIFORNIA 91355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/12/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		P(1)		2,000	A	$3.97	152,927(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code.

2. Includes unvested RSUs

	/s/ David O'Toole	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)